| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.1 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.1 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.1 |